The Challenge: How do we fight the growing burden on non-communicable disease worldwide?
While many advances have been made to improve the health and wellbeing of vulnerable groups around the world, there is still a great distance that we must go to meet the targets laid out in SDG 3. This goal includes indicators for reproductive, maternal, new-born and child health; infectious diseases; non-communicable diseases and mental health and health systems and funding.
Specific to SDG 3, we have focused our Lead2030 Challenge on SDG 3.4: to reduce by one third premature mortality from non-communicable diseases (NCDs) through prevention and treatment and to promote mental health and well-being. NCDs have emerged to become the number one cause of morbidity and mortality worldwide, killing more than 41 million people each year. While they disproportionately impact people living in vulnerable or compromised situations, they are an issue for people everywhere. Young people are most at risk and they are also the point of great opportunity to change the trajectory of disease. Yet young people are seldom on the global health agenda. 70% of premature deaths from NCDs can be linked to behaviours and habits that form in adolescence. Prevention becomes a critical tool to fight the burden of NCDs. Through our Young Health Programme we invest in education, advocacy and research to address the primary risk factors that lead to NCDs in later life.
The Lead2030 Challenge for SDG3 supported by AstraZeneca launched a global search for impactful youth-led initiatives working to tackle the growing burden on non-communicable diseases.
Quinn Underwood, Advin
ADVIN’s approach to providing high-quality and low-cost primary care has two pillars:
- Engagement: ADVIN works with trusted community partners with existing rural centres and infrastructure to run health literacy campaigns to introduce concepts of health monitoring and digital health in rural populations.
- Technology: ADVIN’s hardware, integrated with a proprietary AI-powered software platform, is able to provide symptom and data based diagnostic recommendations with incredible accuracy and efficiency. Health workers gather information through urine and blood test strips (and other health devices) to enter into the device, providing diagnostic recommendation and storing the information on a cloud-based database accessible by remote doctors.
The two-pronged approach allows healthcare workers to monitor vital signs and screen for the most major communicable and non-communicable diseases on-site, thus improving quality of care and drastically reducing improper prescription of medication. ADVIN’s current model can perform 62 separate diagnostic tests, collecting the data necessary to diagnose over 300 diseases.
ADVIN has provided healthcare screening to more than 100,000 individuals across South Asia and is currently in the process of rolling out 1,000 primary health care centres (selected with in partnership with the Government of Bangladesh) to serve approx. 4.6 million individuals across Bangladesh.
By focusing on diseases such as pregnancy-related diabetes, family planning and maternal and child health, ADVIN has created impact on vulnerable women and children.
“We speak of preventable diseases but have continually refused to take the action necessary in preventing them. This can go on no further.”